Startup Strategies: How to Maximize the Value of Your BioPharma IP September 2, 2010

Maximizing the value of your BioPharma IP begins with being strategic about your end-game. You want to pay less and achieve more from your innovations and investments, and to minimize the risk of losing ownership or control over what's rightfully yours. The smart approach? Develop an IP strategy that considers your full potential for licensing, investment, merger and acquisition while delivering full protection for your patentable assets.

Join startup strategists from Townsend and Townsend and Crew, Aquilo Partners and SageSpring Partners to learn how companies today are managing to get more value for their dollar by developing integrated IP and business strategies that minimize their risks and maximize their investment value.

Our programs are candid, interactive and informal. We want you to walk away with the real story behind how things work so you can make it happen yourself.

Speakers
* William Kezer, Partner, Townsend and Townsend and Crew LLP
* Ethan Fingerman, Vice President, Aquilo Partners
* Leslie Lippard, Partner, Sage Spring Partners
* Moderator: Richard Hsu, Partner, Townsend and Townsend and Crew LLP

Official Website: http://www.sjbiocenter.com/event/ev_2010Q3-MaximizeIPvalue.html